Oncologic Emergencies and Immunotherapy-Related Toxicities

Schedule:       May 20, 2021

                        Live Virtual Session – 12 noon and again at 3pm, Bangor ME

Audience:       Accredited for Pharmacists and Technicians

                        Other interested health care professionals welcome

Credits:          1 Contact Hour of Knowledge-based

                        1.0 CEUs will be awarded under the provider                                                             

Presenter(s):    Kristin Youngblood, PharmD, Clinical Pharmacist of Oncology, Northern Light Eastern Maine Medical Center

No charge for CE

Learning Objectives for Pharmacists:

0837-9999-21-121-L01-P

After attending this program, participants will be able to:

1. Describe the appropriate treatment of hypercalcemia of malignancy based on severity
2. Identify patients who are at risk of developing tumor lysis syndrome
3. Outline a prevention strategy for tumor lysis syndrome
4. Recognize the appropriate management of immunotherapy-related colitis based on severity

Learning Objectives for Technicians:

0837-9999-21-122-L01-T

1. Recall how to calculate corrected calcium
2. List risk factors for developing tumor lysis syndrome
3. Describe the role of corticosteroids for the treatment of immunotherapy-related toxicities